Skip to content

Icon PLC

ICLR· NasdaqCore metricsCIK 1060955

Commercial physical & biological research16 peers

Last sale
Nov 12, 2026 · +0.49%
Market cap
—
no share count on file
Filings
845
$2.02B
Q3 2026+0.8% FY25 yoy
$122.13M
Q3 2026−69.0% FY25 yoy
$198.84M
Q3 2026−57.1% FY25 yoy
$682.23M
Q3 2026derived−22.9% FY25 yoy
$1.58
Q3 2026−67.4% FY25 yoy
$808.98M
Q3 2026+20.1% FY25 yoy

Price

$200.38+22.62%+$36.96past year
Nov 12, 2026 · IEX last sale
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$8.25BFY 2025
$8.25B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$8,251,340,000reported
FY 20242024-12-31$8,188,990,000 revisedreported
FY 20232023-12-31$8,054,926,000 revisedreported
FY 20222022-12-31$7,741,386,000reported
FY 20212021-12-31$5,480,826,000reported
FY 20202020-12-31$2,797,288,000reported
FY 20192019-12-31$2,805,839,000reported
FY 20182018-12-31$2,595,777,000reported
FY 20172017-12-31$1,758,439,000reported
FY 20162016-12-31$1,666,487,000reported
FY 20152015-12-31$1,574,978,000reported
FY 20142014-12-31$1,503,316,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$750.00M$750.00M—76.57M sh−5.2%87.0%
FY2024—$500.00M$500.00M—80.76M sh−2.1%44.7%
FY2023—$0.00$0.00—82.50M sh+0.9%0.0%
FY2022—$99.98M$99.98M—81.72M sh+0.2%23.7%
FY2021—$0.00$0.00—81.55M sh+54.5%0.0%

Segments

Geography
Revenue by Geography, FY2018 to FY2025FY2018Ireland · FY2018 · $1.07BUnited States · FY2018 · $894.98MRest of Europe · FY2018 · $379.88MOther · FY2018 · $254.72MFY2019Ireland · FY2019 · $1.25BUnited States · FY2019 · $892.50MRest of Europe · FY2019 · $388.92MOther · FY2019 · $271.59MFY2020Ireland · FY2020 · $1.18BUnited States · FY2020 · $925.56MRest of Europe · FY2020 · $416.88MOther · FY2020 · $273.55MFY2021Ireland · FY2021 · $1.37BUnited States · FY2021 · $2.58BRest of Europe · FY2021 · $1.18BOther · FY2021 · $358.40MFY2022Ireland · FY2022 · $1.98BUnited States · FY2022 · $3.57BRest of Europe · FY2022 · $1.62BOther · FY2022 · $563.86MFY2023Ireland · FY2023 · $2.32BUnited States · FY2023 · $3.28BRest of Europe · FY2023 · $1.57BRest of World · FY2023 · $884.50MOther · FY2023 · $884.50MFY2024Ireland · FY2024 · $2.70BUnited States · FY2024 · $2.98BRest of Europe · FY2024 · $1.56BRest of World · FY2024 · $942.64MOther · FY2024 · $942.64MFY2025Ireland · FY2025 · $3.18BUnited States · FY2025 · $2.52BRest of Europe · FY2025 · $1.59BRest of World · FY2025 · $951.90M
LineFY2025ShareChange
Ireland$3.18B39%+17.7%
United States$2.52B31%−15.4%
Rest of Europe$1.59B19%+2.0%
Rest of World$951.90M12%+1.0%
Other———
Total$8.25B

From the 20-F filed May 27, 2026ICLR

Commercial physical & biological research

Icon PLC is the 2nd largest of the 17 covered companies the SEC files under this code, by revenue. SIC 8731

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Icon PLC · CIK 1060955 · Engraved from SEC EDGAR